Key concepts in glioblastoma therapy

J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):753-60. doi: 10.1136/jnnp-2011-300709. Epub 2012 Mar 6.


Glioblastoma is the most common form of primary brain cancer and remains one of the most aggressive forms of human cancer. Current standard of care involves maximal surgical resection followed by concurrent therapy with radiation and the DNA alkylating agent temozolomide. Despite this aggressive regimen, the median survival remains approximately 14 months. Meaningful strategies for therapeutic intervention are desperately needed. Development of such strategies will require an understanding of the therapeutic concepts that have evolved over the past three decades. This article reviews the key principles that drive the formulation of therapeutic strategies in glioblastoma. Specifically, the concepts of tumour heterogeneity, oncogene addiction, non-oncogene addiction, tumour initiating cells, tumour microenvironment, non-coding sequences and DNA damage response will be reviewed.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain Neoplasms / genetics*
  • Brain Neoplasms / therapy
  • Combined Modality Therapy
  • DNA Damage / genetics
  • DNA, Neoplasm / genetics
  • Glioblastoma / genetics*
  • Glioblastoma / therapy
  • Humans
  • Oncogenes / genetics
  • RNA, Untranslated / genetics


  • DNA, Neoplasm
  • RNA, Untranslated